Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1908 to 1957 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1908\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to cg7020 gene product (fragment). [source:sptrembl;acc:q96ib4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
191.415\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
193.394\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01034\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1909\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calmegin precursor. [source:swissprot;acc:o14967]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.48\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.256\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01033\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1910\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calnexin precursor (major histocompatibility complex class i antigen-binding protein p88) (p90) (ip90). [source:swissprot;acc:p27824]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1911\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
soluble liver antigen/liver pancreas antigen. [source:refseq;acc:nm\_153825]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1912\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna (guanine-7-) methyltransferase. [source:refseq;acc:nm\_003799]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1913\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phospholipid scramblase 3 (pl scramblase 3) (ca(2+)-dependent phospholipid scramblase 3). [source:swissprot;acc:q9nry6]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
215.745\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.564\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01021\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1914\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phospholipid scramblase 4 (pl scramblase 4) (ca(2+)-dependent phospholipid scramblase 4). [source:swissprot;acc:q9nrq2]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1915\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phospholipid scramblase 2 (pl scramblase 2) (ca(2+)-dependent phospholipid scramblase 2). [source:swissprot;acc:q9nry7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.747\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.571\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01019\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1916\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rh type c glycoprotein. [source:refseq;acc:nm\_016321]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
196.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01016\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1917\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
p28 ing5. [source:refseq;acc:nm\_032329]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.848\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.039\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01015\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1918\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
endothelial-derived gene 1. [source:refseq;acc:nm\_025205]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
202.211\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
200.18\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1919\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histidyl-trna synthetase homolog (ec 6.1.1.21) (histidine--trna ligase homolog) (hisrs). [source:swissprot;acc:p49590]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.231\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
185.349\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1920\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histidyl-trna synthetase (ec 6.1.1.21) (histidine--trna ligase) (hisrs). [source:swissprot;acc:p12081]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
187.292\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
185.413\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01013\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1921\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5-methyltetrahydrofolate--homocysteine methyltransferase (ec 2.1.1.13) (methionine synthase, vitamin-b12 dependent) (ms). [source:swissprot;acc:q99707]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
221.607\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.386\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01012\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1922\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
centaurin gamma 2. [source:swissprot;acc:q9upq3]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
220.659\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.452\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0101\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1923\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
general vesicular transport factor p115 (transcytosis associated protein) (tap) (vesicle docking protein). [source:swissprot;acc:o60763]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1924\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
centaurin gamma 1. [source:swissprot;acc:q99490]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1925\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
centaurin gamma 3. [source:swissprot;acc:q96p47]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1926\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rhesus blood group, b glycoprotein; rh type b glycoprotein. [source:refseq;acc:nm\_020407]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
196.925\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01008\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1927\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rhesus blood group-associated glycoprotein (erythrocyte plasma membrane 50 kda glycoprotein) (rh50a). [source:swissprot;acc:q02094]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
196.932\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.914\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01006\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1928\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
blood group rh(d) polypeptide (rhesus d antigen) (rhxiii) (rh polypeptide 2) (rhpii). [source:swissprot;acc:q02161]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
196.964\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.935\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01001\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1929\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
enigma protein; lim domain protein. [source:refseq;acc:nm\_005451]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.753\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.574\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1930\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
blood group rh(ce) polypeptide (rhesus c/e antigens) (rh30a) (rhixb) (rh polypeptide 1) (rhpi). [source:swissprot;acc:p18577]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
196.964\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.935\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1931\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 3 subunit 7 (eif-3 zeta) (eif3 p66) (eif3d). [source:swissprot;acc:o15371]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.753\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.574\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1932\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
blood group rh(ce) polypeptide (rhesus c/e antigens) (rh30a) (rhixb) (rh polypeptide 1) (rhpi). [source:swissprot;acc:p18577]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
196.965\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
198.936\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1933\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine carbamoyltransferase, mitochondrial precursor (ec 2.1.3.3) (otcase) (ornithine transcarbamylase). [source:swissprot;acc:p00480]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.667\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00998\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1934\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gamma adducin (adducin-like protein 70). [source:swissprot;acc:q9uey8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
224.264\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.055\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00995\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1935\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
abhydrolase domain containing protein 2 (protein phps1-2). [source:swissprot;acc:p08910]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.279\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1936\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
creatine kinase, sarcomeric mitochondrial precursor (ec 2.7.3.2) (s- mtck) (mib-ck) (basic-type mitochondrial creatine kinase). [source:swissprot;acc:p17540]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.347\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1937\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
quaking isoform 6. [source:sptrembl;acc:q9p0x9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.279\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1938\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
creatine kinase, ubiquitous mitochondrial precursor (ec 2.7.3.2) (u- mtck) (mia-ck) (acidic-type mitochondrial creatine kinase). [source:swissprot;acc:p12532]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.293\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.341\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00994\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1939\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptidyl prolyl isomerase h; cyclophilin h. [source:refseq;acc:nm\_006347]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.258\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.319\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00988\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1940\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
creatine kinase, b chain (ec 2.7.3.2) (b-ck). [source:swissprot;acc:p12277]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
196.252\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1941\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
prp18 pre-mrna processing factor 18 homolog. [source:refseq;acc:nm\_003675]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.258\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
196.319\vspace{3pt}}}&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1942\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
j domain protein c21orf55. [source:swissprot;acc:q9nx36]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
198.257\vspace{3pt}}&&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00987\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1943\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
megf11 protein. [source:refseq;acc:nm\_032445]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
224.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.147\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1944\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
megf10 protein. [source:refseq;acc:nm\_032446]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
224.341\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.148\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1945\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta adducin (erythrocyte adducin beta subunit). [source:swissprot;acc:p35612]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
224.343\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
222.151\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1946\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear factor, interleukin 3 regulated. [source:refseq;acc:nm\_005384]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.234\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.142\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00986\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1947\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase inhibitor 2 (ipp-2). [source:swissprot;acc:p41236]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
125.845\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
127.083\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00984\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1948\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
15 kda selenoprotein precursor. [source:swissprot;acc:o60613]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.522\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.432\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1949\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna-binding protein with multiple splicing (rbp-ms). [source:swissprot;acc:q93062]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.794\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.663\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1950\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar protein sorting 18 (hvps18). [source:swissprot;acc:q9p253]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.847\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.747\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00982\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1951\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
trna isopentenylpyrophosphate transferase. [source:refseq;acc:nm\_017646]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
205.876\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.873\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1952\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-1 subunit (karyopherin alpha-1 subunit) (srp1-beta) (rag cohort protein 2) (nucleoprotein interactor 1) (npi-1). [source:swissprot;acc:p52294]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
211.647\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.724\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00981\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1953\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
type 1 protein phosphatase inhibitor. [source:refseq;acc:nm\_025210]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
125.912\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
127.146\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0098\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1954\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-gated potassium channel beta-3 subunit (k+ channel beta-3 subunit) (kv-beta-3). [source:swissprot;acc:o43448]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
211.632\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
213.703\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00979\vspace{3pt}}\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1955\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
yip1 interacting factor homolog; yip1p-interacting factor; putative rab5-interacting protein; putative transmembrane protein 54tmp. [source:refseq;acc:nm\_020470]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
211.633\vspace{3pt}}}&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00978\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1956\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-gated potassium channel beta-1 subunit (k+ channel beta-1 subunit) (kv-beta-1). [source:swissprot;acc:q14722]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1957\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to putative transmembrane protein; homolog of yeast golgi membrane protein yif1p (yip1p-interacting factor). [source:refseq;acc:nm\_033557]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/